In PD, increased expression of interleukin (IL)-1β was already reported in striatum, CSF, and peripheral blood mononuclear cells; increased IL-1β expression has been used as a sensitive and specific marker of caspase-1 activation since caspase-1 is the major activator of pro-IL-1β. Here, CASP1 is linked to Parkinson disease.